PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.\', \'Space Exploration Technologies Corp, Hawthorne, CA, USA.\', \'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Brigham and Women\'s Hospital, Boston, MA, USA.\', \'Moderna Inc, Cambridge, MA, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA. Electronic address: galter@mgh.harvard.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1074-7613(22)00030-910.1016/j.immuni.2022.01.001
?:hasPublicationType
?:journal
  • Immunity
is ?:pmid of
?:pmid
?:pmid
  • 35090580
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 13.393
?:rankingScore_hIndex
  • 342
is ?:relation_isRelatedTo_publication of
?:title
  • mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all